Worldwide, over 30% of all deaths are attributable to cardiovascular disease (CVD). The increasing incidence and high cost of care of CVDs demand a global approach to prevention, early detection & treatment, and monitoring of disease progression. Used in conjunction with clinical information, cardiac biomarkers are crucial to support rapid and accurate diagnosis, especially in acute cases where every minute counts.
Although widespread, diabetes is often not appropriately diagnosed or incorrectly managed. Very few people with the condition actually reach their personal therapy targets. This state of affairs is primarily attributable to clinical inertia—in other words, lack of motivation, depressive states or too little time with a doctor.